Elanco Animal Health Long Term Debt 2016-2023 | ELAN
Elanco Animal Health long term debt from 2016 to 2023. Long term debt can be defined as the sum of all long term debt fields.
- Elanco Animal Health long term debt for the quarter ending December 31, 2023 was $5.736B, a 5.29% increase year-over-year.
- Elanco Animal Health long term debt for 2023 was $5.736B, a 5.29% increase from 2022.
- Elanco Animal Health long term debt for 2022 was $5.448B, a 9.58% decline from 2021.
- Elanco Animal Health long term debt for 2021 was $6.025B, a 8.13% increase from 2020.
| Elanco Animal Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $5,736 |
| 2022 | $5,448 |
| 2021 | $6,025 |
| 2020 | $5,572 |
| 2019 | $2,331 |
| 2018 | $2,443 |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| Elanco Animal Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-12-31 | $5,736 |
| 2023-09-30 | $5,870 |
| 2023-06-30 | $6,023 |
| 2023-03-31 | $5,639 |
| 2022-12-31 | $5,448 |
| 2022-09-30 | $5,507 |
| 2022-06-30 | $6,007 |
| 2022-03-31 | $6,073 |
| 2021-12-31 | $6,025 |
| 2021-09-30 | $6,273 |
| 2021-06-30 | $5,542 |
| 2021-03-31 | $5,556 |
| 2020-12-31 | $5,572 |
| 2020-09-30 | $5,587 |
| 2020-06-30 | $2,030 |
| 2020-03-31 | $2,036 |
| 2019-12-31 | $2,331 |
| 2019-09-30 | $2,336 |
| 2019-06-30 | $2,382 |
| 2019-03-31 | $2,437 |
| 2018-12-31 | $2,443 |
| 2018-09-30 | $2,479 |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $8.345B | $4.417B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.090B | 10.34 |
| Quest Diagnostics (DGX) | United States | $15.124B | 15.63 |
| DaVita (DVA) | United States | $11.914B | 14.80 |
| Chemed (CHE) | United States | $8.670B | 26.88 |
| Encompass Health (EHC) | United States | $8.587B | 21.98 |
| Option Care Health (OPCH) | United States | $5.253B | 19.88 |
| RadNet (RDNT) | United States | $3.741B | 77.89 |
| Amedisys (AMED) | United States | $3.074B | 21.78 |
| LifeStance Health (LFST) | United States | $2.668B | 0.00 |
| Astrana Health (ASTH) | United States | $2.134B | 28.86 |
| Addus HomeCare (ADUS) | United States | $1.753B | 25.08 |
| U.S Physical Therapy (USPH) | United States | $1.566B | 41.90 |
| Pennant (PNTG) | United States | $0.665B | 35.14 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.466B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.337B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |